SIM
ARRY

SSI Investment Management’s Array Biopharma Inc ARRY Stock Holding History

SSI Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-96,590
Closed -$345K – 410
2014
Q3 		$345K Sell
96,590
-6,950
-7% -$27.4K 0.03% 284
2014
Q2 		$473K Buy
+103,540
New +$428K 0.05% 241

Other funds holding ARRY

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

SSI Investment Management's ARRY Position: Q4 2014 in Review

SSI Investment Management sold out of Array Biopharma Inc (ARRY) in Q4 2014, closing a stake of 96,590 shares — an estimated $345K sold.

SSI Investment Management first reported a position in ARRY in Q2 2014 and held it in 2 quarters. The position peaked at $473K in Q2 2014. 122 funds tracked by Wall St. Rank hold ARRY as of Q4 2014.

  • SSI Investment Management reported no remaining Array Biopharma Inc position as of Q4 2014 after selling out during the quarter.
  • SSI Investment Management sold 96,590 Array Biopharma Inc shares in Q4 2014, an estimated $345K.
  • SSI Investment Management first reported a position in Array Biopharma Inc in Q2 2014 and held it in 2 quarters.
  • SSI Investment Management's Array Biopharma Inc position peaked at $473K in Q2 2014.
  • 122 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2014.

Based on SSI Investment Management's 13F filing for Q4 2014, filed 11 Feb 2015.